434 related articles for article (PubMed ID: 21700929)
1. Ets2 determines the inflammatory state of endothelial cells in advanced atherosclerotic lesions.
Cheng C; Tempel D; Den Dekker WK; Haasdijk R; Chrifi I; Bos FL; Wagtmans K; van de Kamp EH; Blonden L; Biessen EA; Moll F; Pasterkamp G; Serruys PW; Schulte-Merker S; Duckers HJ
Circ Res; 2011 Aug; 109(4):382-95. PubMed ID: 21700929
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
5. Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system.
Katsume A; Okigaki M; Matsui A; Che J; Adachi Y; Kishita E; Yamaguchi S; Ikeda K; Ueyama T; Matoba S; Yamada H; Matsubara H
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1084-92. PubMed ID: 21372295
[TBL] [Abstract][Full Text] [Related]
6. Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation.
Wei HJ; Li YH; Shi GY; Liu SL; Chang PC; Kuo CH; Wu HL
Cardiovasc Res; 2011 Nov; 92(2):317-27. PubMed ID: 21840881
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis.
Hakimi M; Peters A; Becker A; Böckler D; Dihlmann S
J Vasc Surg; 2014 Mar; 59(3):794-803. PubMed ID: 23790454
[TBL] [Abstract][Full Text] [Related]
8. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
[TBL] [Abstract][Full Text] [Related]
9. Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids.
Wu BJ; Yan L; Charlton F; Witting P; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):968-75. PubMed ID: 20167660
[TBL] [Abstract][Full Text] [Related]
10. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
[TBL] [Abstract][Full Text] [Related]
11. THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice.
Haasdijk RA; Den Dekker WK; Cheng C; Tempel D; Szulcek R; Bos FL; Hermkens DM; Chrifi I; Brandt MM; Van Dijk C; Xu YJ; Van De Kamp EH; Blonden LA; Van Bezu J; Sluimer JC; Biessen EA; Van Nieuw Amerongen GP; Duckers HJ
Cardiovasc Res; 2016 May; 110(1):129-39. PubMed ID: 26822228
[TBL] [Abstract][Full Text] [Related]
12. Cell death-mediated cleavage of the attraction signal p43 in human atherosclerosis: implications for plaque destabilization.
Martinet W; De Meyer I; Cools N; Timmerman V; Bult H; Bosmans J; De Meyer GR
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1415-22. PubMed ID: 20413730
[TBL] [Abstract][Full Text] [Related]
13. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
[TBL] [Abstract][Full Text] [Related]
14. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.
Thomas MC; Pickering RJ; Tsorotes D; Koitka A; Sheehy K; Bernardi S; Toffoli B; Nguyen-Huu TP; Head GA; Fu Y; Chin-Dusting J; Cooper ME; Tikellis C
Circ Res; 2010 Oct; 107(7):888-97. PubMed ID: 20671240
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis.
da Cunha V; Martin-McNulty B; Vincelette J; Choy DF; Li WW; Schroeder M; Mahmoudi M; Halks-Miller M; Wilson DW; Vergona R; Sullivan ME; Wang YX
J Vasc Surg; 2006 Aug; 44(2):364-71. PubMed ID: 16890870
[TBL] [Abstract][Full Text] [Related]
16. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation.
Wan JB; Huang LL; Rong R; Tan R; Wang J; Kang JX
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2487-94. PubMed ID: 20705919
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
Cipriani S; Francisci D; Mencarelli A; Renga B; Schiaroli E; D'Amore C; Baldelli F; Fiorucci S
Circulation; 2013 May; 127(21):2114-24. PubMed ID: 23633271
[TBL] [Abstract][Full Text] [Related]
18. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice.
Olofsson PS; Söderström LA; Wågsäter D; Sheikine Y; Ocaya P; Lang F; Rabu C; Chen L; Rudling M; Aukrust P; Hedin U; Paulsson-Berne G; Sirsjö A; Hansson GK
Circulation; 2008 Mar; 117(10):1292-301. PubMed ID: 18285570
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
[TBL] [Abstract][Full Text] [Related]
20. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
